Trial intelligence / Profile preview

Effect of levothyroxine on serum lipids in patients with subclinical hypothyroidism

IRCT2014051417686N1Phase 2Completed

Sponsor
Qom University of Medical Sciences
Start
Mar 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of levothyroxine sodium in hypothyroidism and dyslipidemia, sponsored by Qom University of Medical Sciences. Primary endpoint: Change in serum lipid profile. Started Mar 2013; status: completed.

02

Drugs

levothyroxine sodium
03

Conditions

hypothyroidismdyslipidemia

Beyond the preview

Go deeper on IRCT2014051417686N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2014051417686N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call